iGuard is a very simple service available to consumers, yet a vital one. Patients who want to hear about recalls for medication or tools can register and sign up to be notified.
The Data Drives Decision was moderated by Indu, with panel speakers such as Jamie Heywood (Co-Founder and Chairman, PatientsLikeMe), David Hale (Project Manager, National Library of Medicine, National Institutes of Health), Hugo Stephenson (Chief Executive Officer and Founder, iGuard), Mark Walinske (Chief Executive Officer, Boundary Medical), and Daniel Palestrant (MD, Chief Executive Officer and Founder, Sermo).
Hugo Stephenson, CEO & Founder, iGuard
Here Hugo speaks about the companies’ expansive service. Launched in 2007, iGuard (now called MediGuard) has over 1.5 million members who benefit from receiving information about interactions and recalls, and are also being recruited for clinical trials and even genomics studies.
Mark Walinske, CEO, Boundary Medical
Mark Walinske is the CEO of Boundary Medical, a company that fulfills a gap of transformation type data by measuring patient reported clinical and functional outcomes both inclusive of the physican as well as the patient. Mark talks about the app they built that is versatile and easy to use.
Chris Kula-Przezwanksi, Founder/President, MediGuard and Pablo Graiver, CEO, Trialreach field question from out expert panel and discuss how to put clinical trials online and make them accessible and popular.
Chris Kula-Przezwanksi, Founder/President, MediGuard
MediGuard (which has changed its name from iGuard) may be the biggest Health 2.0 membership site of all. Launched in 2007 as a spin-off of Quintiles, where Hugo was a senior executive, iGuard now has in excess of 2 million members in the US and another 100K plus in the UK. They’re getting information about interactions and recalls, being involved in frequent studies and are also being recruited for clinical trials. Hugo is a frequent visitor to the US but has been living in Paris. He’s moving back to his native Australia very soon. Ready for Health 2.0 Australia perhaps?